Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $405.84 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $142.01 | 2 | $0 (2024) |
| GlaxoSmithKline, LLC. | $120.21 | 1 | $0 (2021) |
| Merck Sharp & Dohme LLC | $87.43 | 4 | $0 (2024) |
| Genmab U.S., Inc. | $56.19 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $123.35 | 5 | Genmab U.S., Inc. ($56.19) |
| 2023 | $124.15 | 1 | AstraZeneca Pharmaceuticals LP ($124.15) |
| 2022 | $17.19 | 1 | Merck Sharp & Dohme LLC ($17.19) |
| 2021 | $141.15 | 2 | GlaxoSmithKline, LLC. ($120.21) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | Genmab U.S., Inc. | Tivdak (Drug) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Oncology | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.86 | General |
| 10/09/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: ONCOLOGY | ||||||
| 08/08/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $25.17 | General |
| Category: ONCOLOGY | ||||||
| 06/14/2024 | Genmab U.S., Inc. | Tivdak (Drug) | Food and Beverage | In-kind items and services | $32.52 | General |
| Category: Oncology | ||||||
| 05/18/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $124.15 | General |
| Category: Oncology | ||||||
| 03/31/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: ONCOLOGY | ||||||
| 11/02/2021 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $120.21 | General |
| Category: ONCOLOGY | ||||||
| 10/28/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: ONCOLOGY | ||||||
About Olesya Razhba, NP
Olesya Razhba, NP is a Oncology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/22/2016. The National Provider Identifier (NPI) number assigned to this provider is 1962861799.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Olesya Razhba, NP has received a total of $405.84 in payments from pharmaceutical and medical device companies, with $123.35 received in 2024. These payments were reported across 9 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($405.84).
Practice Information
- Specialty Oncology
- Other Specialties Family
- Location New York, NY
- Active Since 02/22/2016
- Last Updated 02/22/2017
- Taxonomy Code 163WX0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1962861799
Products in Payments
- LYNPARZA (Drug) $124.15
- ZEJULA (Drug) $120.21
- KEYTRUDA (Biological) $87.43
- Tivdak (Drug) $56.19
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Oncology Doctors in New York
Ms. Ellen Neylon, N.p, N.P
Oncology — Payments: $123,426
Caroline Buhion
Oncology — Payments: $5,314
Yvette Doan-Schultz, Anp, ANP
Oncology — Payments: $1,395
Leila Liu-Nguyen
Oncology — Payments: $1,038
Zulay Fernandez, Cnp, CNP
Oncology — Payments: $529.79
Catherine Handy, Ph.d., Rn, PH.D., RN
Oncology — Payments: $513.70